论文信息 - FDA Approval of Eteplirsen for Muscular Dystrophy. - 字舞流文

FDA Approval of Eteplirsen for Muscular Dystrophy.

J. Sackner-Bernstein

[1] A. Kesselheim,et al. Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy. , 2016, JAMA.

[2] J. Mendell,et al. Eteplirsen for the treatment of Duchenne muscular dystrophy , 2013, Annals of neurology.